![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » PAR NAMES CEO TO LEAD TRANSITION TO BRANDED DRUGS
PAR NAMES CEO TO LEAD TRANSITION TO BRANDED DRUGS
Par Pharmaceutical Cos., a generic-drug maker being scrutinized by U.S. regulators, said Tuesday that it named Patrick G. LePore, 51, as president and chief executive officer to replace Scott Tarriff, 47, who was fired.
NorthJersey.com (http://www.northjersey.com/page.php?qstr=eXJpcnk3ZjczN2Y3dnFlZUVFeXkyOSZmZ2JlbDdmN3ZxZWVFRXl5Njk5NzM4NyZ5cmlyeTdmNzE3Zjd2cWVlRUV5eTI=)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct